These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16861219)

  • 41. Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial.
    Martinez E; Gonzalez-Cordon A; Ferrer E; Domingo P; Negredo E; Gutierrez F; Portilla J; Curran A; Podzamczer D; Ribera E; Murillas J; Bernardino JI; Santos I; Carton JA; Peraire J; Pich J; Deulofeu R; Perez I; Gatell JM;
    Clin Infect Dis; 2015 Mar; 60(5):811-20. PubMed ID: 25389256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
    Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
    Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
    Molina JM; Andrade-Villanueva J; Echevarria J; Chetchotisakd P; Corral J; David N; Moyle G; Mancini M; Percival L; Yang R; Thiry A; McGrath D;
    Lancet; 2008 Aug; 372(9639):646-55. PubMed ID: 18722869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults.
    Samaras K; Richardson R; Carr A
    AIDS; 2010 Jul; 24(11):1727-31. PubMed ID: 20588105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes.
    Treijtel N; van Eijkeren JC; Nijmeijer S; de Greef-van der Sandt IC; Freidig AP
    Toxicol In Vitro; 2009 Feb; 23(1):185-93. PubMed ID: 19038324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of the LDL receptor and LRP levels by HIV protease inhibitors.
    Tran H; Robinson S; Mikhailenko I; Strickland DK
    J Lipid Res; 2003 Oct; 44(10):1859-69. PubMed ID: 12837856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors.
    Allred KF; Smart EJ; Wilson ME
    J Biol Chem; 2006 Jan; 281(3):1419-25. PubMed ID: 16299001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir.
    Roy-Chowdhury J; Roy-Chowdhury N; Listowsky I; Wolkoff AW
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):140-146. PubMed ID: 28263463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.
    Lee GA; Rao MN; Grunfeld C
    Curr HIV/AIDS Rep; 2005 Feb; 2(1):39-50. PubMed ID: 16091248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes.
    Nicolaï J; De Bruyn T; Thevelin L; Augustijns P; Annaert P
    Drug Metab Dispos; 2016 Mar; 44(3):389-97. PubMed ID: 26712820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Effects of HIV Protease Inhibitors on Carbohydrate and Lipid Metabolism.
    Lee GA; Rao MN; Grunfeld C
    Curr Infect Dis Rep; 2004 Dec; 6(6):471-482. PubMed ID: 15538985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration of liver immunity by increasing inflammatory response during co-administration of methamphetamine and atazanavir.
    Li Y; Li S; Xia Y; Li X; Chen T; Yan J; Wang Y
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):237-245. PubMed ID: 32249638
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system.
    Omori H; Chikamoto J; Nagahara M; Hirata M; Otoi T
    Toxicol In Vitro; 2023 Dec; 93():105689. PubMed ID: 37660998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IFN-α-2b induces apoptosis by decreasing cellular cholesterol levels in rat preneoplastic hepatocytes.
    Quiroga AD; Vera MC; Ferretti AC; Lucci A; Comanzo CG; Lambertucci F; Ceballos MP; Carrillo MC
    Cytokine; 2020 Sep; 133():155172. PubMed ID: 32590329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amprenavir : A Viewpoint by Graeme Moyle.
    Moyle G
    Drugs; 1998 Jun; 55(6):843-4. PubMed ID: 27518723
    [No Abstract]   [Full Text] [Related]  

  • 56. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas.
    Papantoniou E; Arvanitakis K; Markakis K; Papadakos SP; Tsachouridou O; Popovic DS; Germanidis G; Koufakis T; Kotsa K
    Life (Basel); 2024 Mar; 14(4):. PubMed ID: 38672720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection.
    Mu W; Patankar V; Kitchen S; Zhen A
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The integrated stress response signaling during the persistent HIV infection.
    Mendes EA; Tang Y; Jiang G
    iScience; 2023 Dec; 26(12):108418. PubMed ID: 38058309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity.
    Bryan A; Pingali P; Faber A; Landry J; Akakpo JY; Jaeschke H; Li H; Lee WS; May L; Patel B; Neuwelt A
    J Pharmacol Exp Ther; 2024 Jan; 388(1):209-217. PubMed ID: 37918853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endoplasmic Reticulum Stress and Mitochondrial Stress in Drug-Induced Liver Injury.
    Pu S; Pan Y; Zhang Q; You T; Yue T; Zhang Y; Wang M
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37049925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.